VEXAS

Clinical trials for VEXAS explained in plain language.

Never miss a new study

Get alerted when new VEXAS trials appear

Sign up with your email to follow new studies for VEXAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare inflammatory disease: pacritinib trial begins

Disease control Recruiting now

This study tests a drug called pacritinib for people with VEXAS syndrome, a rare genetic condition that causes severe inflammation. About 78 adults will receive either one of two doses of pacritinib or a placebo to see if it helps control symptoms. The goal is to find the best do…

Matched conditions: VEXAS

Phase: PHASE2 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control

Last updated May 18, 2026 12:12 UTC

VEXAS

Get alerted when new VEXAS trials appear

New hope for rare inflammatory disease: pacritinib trial begins